Bio-Techne

Yahoo Finance • yesterday

Abeona Therapeutics lowers loan interest rate and issues warrants in loan amendment

Abeona Therapeutics Inc. (NASDAQ:ABEO) announced Friday that it has amended its existing Loan and Security Agreement with Avenue Venture Opportunities Fund, L.P. and Avenue Venture Opportunities Fund II, L.P. The amendment reduces the inte... Full story

Yahoo Finance • 4 days ago

Here’s Headwaters Capital Management’s Investment Thesis for Bio-Techne (TECH)

Headwaters Capital Management, an investment management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here. The portfolio bounced back from the first quarter uncertainty and, like the res... Full story

Yahoo Finance • 5 days ago

H.C. Wainwright maintains Buy rating on Abeona Therapeutics stock despite FDA setback

Investing.com - H.C. Wainwright has reiterated its Buy rating and $20.00 price target on Abeona Therapeutics (NASDAQ:ABEO), currently trading at $5.74 with a market cap of $294 million, following the FDA’s Complete Response Letter (CRL) fo... Full story

Yahoo Finance • 18 days ago

Renk CEO calls for defense industry consolidation to boost Europe’s military competitiveness

[Close-up of toy tanks against the background of unfolded euro notes and the European flag] Olena Bartienieva/iStock via Getty Images Europe’s defense industry needs to consolidate to enhance its competitiveness as it scales up production... Full story

Yahoo Finance • 24 days ago

Life sciences tools companies higher as NIH pauses cancellation of research grants

[Wide Angle Shot of a Clean and Organized Modern Laboratory] Tom Werner * Several life sciences tools companies closed noticably higher Wednesday following a report that the NIH has issued a memo not to cancel funding for any more resea... Full story

Yahoo Finance • 25 days ago

Bio-Techne Partners With USP To Distribute MAb And AAV Standards For Biotherapeutic Development

(RTTNews) - Bio-Techne Corporation (TECH) has entered a distribution agreement with the U.S. Pharmacopeia - USP, allowing it to sell USP monoclonal antibody - mAb and adeno-associated virus - AAV reference standards alongside its analytica... Full story

Yahoo Finance • 25 days ago

Bio-Techne and USP to accelerate monoclonal antibody and gene therapy product development

Bio-Techne (NASDAQ:TECH [https://seekingalpha.com/symbol/TECH]) signed [https://seekingalpha.com/pr/20145256-bio-techne-and-usp-announce-collaboration-to-accelerate-monoclonal-antibody-and-gene-therapy] a distribution agreement with the U.... Full story

Yahoo Finance • 25 days ago

Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development

MINNEAPOLIS, June 24, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced a distribution agreement with the U.S. Pharmacopeia (USP) that enables the Company to sell USP monoclonal antibody (mAb) and recombinant adeno... Full story

Yahoo Finance • 2 months ago

Biotech Alert: Searches spiking for these stocks today

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Protect Your Portfolio Against Market Uncertainty Discover companies with rock-solid fundament... Full story

Yahoo Finance • 2 months ago

Bio Techne (TECH) Fell on Negative Funding Environment

Mairs & Power, an investment advisor, released the “Mairs & Power Balanced Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. The stock market reached a record high in February. However, tariff uncertain... Full story

Yahoo Finance • 4 months ago

Bio-Techne (NASDAQ:TECH) shareholders have earned a 8.3% CAGR over the last five years

Bio-Techne Corporation (NASDAQ:TECH) shareholders might be concerned after seeing the share price drop 17% in the last quarter. On the bright side the share price is up over the last half decade. Unfortunately its return of 46% is below th... Full story

Yahoo Finance • 5 months ago

JT Toppin (41 points) leads No. 12 Texas Tech past ASU in 2 OTs

JT Toppin scored a career-high 41 points and secured a steal with 33 seconds remaining in the second overtime as No. 12 Texas Tech escaped with a wild 111-106 win over Arizona State on Wednesday in Lubbock, Texas.... Full story

Yahoo Finance • 5 months ago

Amid DeepSeek frenzy, Chinese companies detail use of AI

Chinese automaker Great Wall Motor and China's leading telecoms providers are integrating the AI model released by DeepSeek into their offerings, the latest Chinese companies looking to capitalize on the start-up's breakthrough and attenti... Full story

Yahoo Finance • 7 months ago

UCF fends off Texas Tech, wins sixth straight

UCF was steady in the first half against Texas Tech, then dominated early in the second to roll into Lubbock and open Big 12 Conference play with a gritty 87-83 triumph on Tuesday.... Full story

Yahoo Finance • 7 months ago

No. 20 North Carolina holds off Georgia Tech in ACC opener

Seth Trimble scored a team-high 19 points, helping lead No. 20 North Carolina to a 68-65 win over visiting Georgia Tech in the Atlantic Coast Conference opener for both teams in Chapel Hill, N.C. on Saturday.... Full story

Yahoo Finance • 8 months ago

TikTok parent ByteDance’s valuation hits $300 billion amid US ban uncertainty, WSJ reports

TikTok's Chinese parent company ByteDance is valuing itself at about $300 billion after a recent buyback offer, the Wall Street Journal reported on Saturday, even as the tech giant's popular TikTok app faces the prospect of a looming ban i... Full story

Yahoo Finance • 9 months ago

ScaleReady announces a G-Rex® Grant has been awarded to renowned cancer immunologist Dr. Christopher A. Klebanoff

ST. PAUL, Minn., Oct. 7, 2024 /PRNewswire/ -- ScaleReady™, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady™, today announced that Christopher A. Klebanoff, MD, a physician-scientist at M... Full story

Yahoo Finance • 10 months ago

BIO-TECHNE ISSUES 2024 CORPORATE SUSTAINABILITY REPORT

MINNEAPOLIS, Sept. 18, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today issued its 2024 Corporate Sustainability Report (CSR), detailing the continued progress advancing its Environmental, Social and Governance (ESG) initia... Full story

Yahoo Finance • 10 months ago

ScaleReady announces a G-Rex® Grant has been awarded to ImmunoScape

ST. PAUL, Minn., Sept. 18, 2024 /PRNewswire/ -- ScaleReady™, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady™, today announced that ImmunoScape Pte. Ltd. (a Singapore-U.S. based TCR-T th... Full story

Yahoo Finance • 10 months ago

Verismo Therapeutics Awarded a ScaleReady™ G-Rex® Grant

PHILADELPHIA, Sept. 17, 2024 /PRNewswire/ -- Verismo Therapeutics, a clinical-stage CAR T company developing the novel KIR-CAR platform technology, today announced that it has been awarded a $150,000 G-Rex Grant by ScaleReady™. This grant... Full story